Probiotix Health (AQSE:PBX) Capital Expenditure : £-0.05 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Probiotix Health's cash flow for capital expenditures for the six months ended in Jun. 2023 was £-0.03 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.05 Mil.

Probiotix Health Capital Expenditure Historical Data

The historical data trend for Probiotix Health's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Capital Expenditure Chart

Probiotix Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec22

Capital Expenditure

-0.13

-0.04

-0.05

Probiotix Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Capital Expenditure	Get a 7-Day Free Trial			-0.02	-0.03	-0.02	-0.02	-0.03

Probiotix Health Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.05 Mil.

Probiotix Health (AQSE:PBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

X90:Germany

Address

Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB

Website

https://www.probiotixhealth-ir.com

Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines